Related Experiment Videos
[Inhibitors of growth factor functions, possible antineoplastic agents]
1Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
SafeSense: An open-access safety atlas for antisense oligonucleotides adverse events in human.
Molecular therapy. Nucleic acids·2026
A highly efficient one-pot approach for the synthesis of novel 5-amino-4-Cyano-Pyrazoles with promising anti-inflammatory and broad-spectrum antimicrobial activity.
Biochemical and biophysical research communications·2026
NiH Catalysis-Enabled Synthesis of 4-Arylpiperidines from Pyridines and Aryl Iodides.
The Journal of organic chemistry·2026